NCT04372485 Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
| NCT ID | NCT04372485 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's National Research Institute |
| Condition | Sexually Transmitted Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 270 participants |
| Start Date | 2024-06-03 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 270 participants in total. It began in 2024-06-03 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
Eligibility Criteria
Inclusion Criteria: * Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment. Exclusion Criteria: * Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Contact & Investigator
Monika Goyal
PRINCIPAL INVESTIGATOR
Children's National Research Institute
Frequently Asked Questions
Who can join the NCT04372485 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 21 Years, studying Sexually Transmitted Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04372485 currently recruiting?
Yes, NCT04372485 is actively recruiting participants. Contact the research team at mdboyle@childrensnational.org for enrollment information.
Where is the NCT04372485 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT04372485 clinical trial?
NCT04372485 is sponsored by Children's National Research Institute. The principal investigator is Monika Goyal at Children's National Research Institute. The trial plans to enroll 270 participants.